Q3 2025 Xtant Medical Holdings Inc Earnings Call Transcript
Key Points
- Xtant Medical Holdings Inc (XTNT) reported a 19% revenue growth over the third quarter of 2024, highlighting strong financial performance.
- The company generated positive cash flow, adjusted EBITDA, and net income, continuing favorable trends from previous quarters.
- The pending sale of noncore assets is expected to bring in $19.2 million, which will be used to reduce long-term debt and enhance cash liquidity.
- Xtant Medical Holdings Inc (XTNT) launched new products, including Collagen X, which is designed to promote healing and prevent infections, expanding their orthobiologics product line.
- The company is investing in R&D and expanding its commercial team to drive growth in its orthobiologics business, aiming for low double-digit growth in 2026.
- The biologics product family grew only 4% over the third quarter of last year, which is below the company's long-term growth expectations.
- There was a 6% decline in hardware product revenue year-over-year, impacting overall revenue growth.
- Operating expenses remain high, with $19.5 million reported for the third quarter, although slightly reduced from the previous year.
- The company is facing challenges in its legacy demineralized bone products, which have seen a decline in sales.
- Xtant Medical Holdings Inc (XTNT) had to reduce its commercial team last year to conserve cash, which impacted sales, and is now in the process of rebuilding.
Good morning, everyone, and welcome to the Xtant Medical third-quarter 2025 financial results. (Operator Instructions) Please note, this conference is being recorded.
I will now turn the conference over to your host, Kevin Gardner of LifeSci Advisors. Kevin, the floor is yours.
Thank you, operator, and welcome to Xtant Medical's third-quarter 2025 financial results call. Joining me today are Sean Browne, President and Chief Executive Officer; and Scott Neils, Chief Financial Officer.
Today's call is being webcast and will be posted on the company's website for playback. During the course of this call, management may make certain forward-looking statements regarding future events and the company's expected future performance.
These forward-looking statements reflect Xtant's current perspective on existing trends and information and can be identified by such words as expect, plan, will, may, anticipate, believe, should, intends and other words with similar meaning.
Such
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
